U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food ...
WASHINGTON – U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced ...
The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who complete their work ahead of schedule. Dr. Marty Makary described the effort as a ...
Following several months of ongoing negotiations between FDA and leaders in the medical device industry, the agency has agreed to commitment letter language for the Medical Device User Fee Amendments ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE - Food and Drug Administration (FDA) commissioner Marty Makary speaks during a news conference at the Hubert Humphrey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results